FdaApplication
ANDA 216140
Identifiers
- fda_app_no: ANDA216140
Properties
| Property | Value |
|---|---|
| applicant_name | BIOCON PHARMA LTD |
| application_type | ANDA |
| approval_date | 2025-04-09 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EVEROLIMUS | EVEROLIMUS | 0.75MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 0.5MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 1MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 0.25MG | TABLET;ORAL |
4 products